244 related articles for article (PubMed ID: 31532776)
21. Serum miRNA signature in Moyamoya disease.
Dai D; Lu Q; Huang Q; Yang P; Hong B; Xu Y; Zhao W; Liu J; Li Q
PLoS One; 2014; 9(8):e102382. PubMed ID: 25093848
[TBL] [Abstract][Full Text] [Related]
22. Expression analysis of transfer RNA‑derived fragments in the blood of patients with moyamoya disease: A preliminary study.
Wang C; Zhao M; Wang J; Zhang D; Wang S; Zhao J
Mol Med Rep; 2019 May; 19(5):3564-3574. PubMed ID: 30896793
[TBL] [Abstract][Full Text] [Related]
23. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
[TBL] [Abstract][Full Text] [Related]
24. APOE as potential biomarkers of moyamoya disease.
Wu H; Xu J; Sun J; Duan J; Xiao J; Ren Q; Zhou P; Yan J; Li Y; Xiong X; Zeng E
Front Neurol; 2023; 14():1156894. PubMed ID: 37228412
[TBL] [Abstract][Full Text] [Related]
25. Identification of diagnostic markers for moyamoya disease by combining bulk RNA-sequencing analysis and machine learning.
Xu Y; Chen B; Guo Z; Chen C; Wang C; Zhou H; Zhang C; Feng Y
Sci Rep; 2024 Mar; 14(1):5931. PubMed ID: 38467737
[TBL] [Abstract][Full Text] [Related]
26. DIAPH1 Variants in Non-East Asian Patients With Sporadic Moyamoya Disease.
Kundishora AJ; Peters ST; Pinard A; Duran D; Panchagnula S; Barak T; Miyagishima DF; Dong W; Smith H; Ocken J; Dunbar A; Nelson-Williams C; Haider S; Walker RL; Li B; Zhao H; Thumkeo D; Marlier A; Duy PQ; Diab NS; Reeves BC; Robert SM; Sujijantarat N; Stratman AN; Chen YH; Zhao S; Roszko I; Lu Q; Zhang B; Mane S; Castaldi C; López-Giráldez F; Knight JR; Bamshad MJ; Nickerson DA; Geschwind DH; Chen SL; Storm PB; Diluna ML; Matouk CC; Orbach DB; Alper SL; Smith ER; Lifton RP; Gunel M; Milewicz DM; Jin SC; Kahle KT
JAMA Neurol; 2021 Aug; 78(8):993-1003. PubMed ID: 34125151
[TBL] [Abstract][Full Text] [Related]
27. Increased serum production of soluble CD163 and CXCL5 in patients with moyamoya disease: Involvement of intrinsic immune reaction in its pathogenesis.
Fujimura M; Fujimura T; Kakizaki A; Sato-Maeda M; Niizuma K; Tomata Y; Aiba S; Tominaga T
Brain Res; 2018 Jan; 1679():39-44. PubMed ID: 29174692
[TBL] [Abstract][Full Text] [Related]
28. Association of apolipoprotein E gene polymorphism with small-vessel lesions and stroke type in moyamoya disease: a preliminary study.
Jang DK; Huh PW; Lee KS
J Neurosurg; 2016 Jun; 124(6):1738-45. PubMed ID: 26566210
[TBL] [Abstract][Full Text] [Related]
29. Potential biomarkers and latent pathways for vasculitis based on latent pathway identification analysis.
Zhou T; Zhang Y; Wu P; Sun Q; Guo Y; Yang Y
Int J Rheum Dis; 2014 Jul; 17(6):671-8. PubMed ID: 24867262
[TBL] [Abstract][Full Text] [Related]
30. Angiogenic and inflammatory responses in human induced microglia-like (iMG) cells from patients with Moyamoya disease.
Shirozu N; Ohgidani M; Hata N; Tanaka S; Inamine S; Sagata N; Kimura T; Inoue I; Arimura K; Nakamizo A; Nishimura A; Maehara N; Takagishi S; Iwaki K; Nakao T; Masuda K; Sakai Y; Mizoguchi M; Yoshimoto K; Kato TA
Sci Rep; 2023 Sep; 13(1):14842. PubMed ID: 37684266
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive molecular analyses of an autoimmune-related gene predictive model and immune infiltrations using machine learning methods in moyamoya disease.
Li S; Han Y; Zhang Q; Tang D; Li J; Weng L
Front Mol Biosci; 2022; 9():991425. PubMed ID: 36605987
[No Abstract] [Full Text] [Related]
32. Mechanisms of Huangqi Decoction Granules () on Hepatitis B Cirrhosis Patients Based on RNA-Sequencing.
Cheng Y; Liu P; Hou TL; Maimaitisidike M; Ababaikeli R; Abudureyimu A
Chin J Integr Med; 2019 Jul; 25(7):507-514. PubMed ID: 30155678
[TBL] [Abstract][Full Text] [Related]
33. Deregulation of Retinaldehyde Dehydrogenase 2 Leads to Defective Angiogenic Function of Endothelial Colony-Forming Cells in Pediatric Moyamoya Disease.
Lee JY; Moon YJ; Lee HO; Park AK; Choi SA; Wang KC; Han JW; Joung JG; Kang HS; Kim JE; Phi JH; Park WY; Kim SK
Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1670-7. PubMed ID: 26023078
[TBL] [Abstract][Full Text] [Related]
34. Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease.
Rafat N; Beck GCh; Peña-Tapia PG; Schmiedek P; Vajkoczy P
Stroke; 2009 Feb; 40(2):432-8. PubMed ID: 19095988
[TBL] [Abstract][Full Text] [Related]
35. The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea.
Park YS; An HJ; Kim JO; Kim WS; Han IB; Kim OJ; Kim NK; Kim DS
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160859
[TBL] [Abstract][Full Text] [Related]
36. Temporal profile of magnetic resonance angiography and decreased ratio of regulatory T cells after immunological adjuvant administration to mice lacking RNF213, a susceptibility gene for moyamoya disease.
Kanoke A; Fujimura M; Niizuma K; Fujimura T; Kakizaki A; Ito A; Sakata H; Sato-Maeda M; Kure S; Tominaga T
Brain Res; 2016 Jul; 1642():1-9. PubMed ID: 26972532
[TBL] [Abstract][Full Text] [Related]
37. Data-Independent Acquisition-Based Serum Proteomic Profiling of Adult Moyamoya Disease Patients Reveals the Potential Pathogenesis of Vascular Changes.
Wang Z; Ji C; Han Q; Wang Z; Huang Y
J Mol Neurosci; 2022 Dec; 72(12):2473-2485. PubMed ID: 36520382
[TBL] [Abstract][Full Text] [Related]
38. Insufficient production of IL-10 from M2 macrophages impairs in vitro endothelial progenitor cell differentiation in patients with Moyamoya disease.
Nagata E; Masuda H; Nakayama T; Netsu S; Yuzawa H; Fujii N; Kohara S; Sorimachi T; Osada T; Imazeki R; Matsumae M; Asahara T; Takizawa S
Sci Rep; 2019 Nov; 9(1):16752. PubMed ID: 31727941
[TBL] [Abstract][Full Text] [Related]
39. Different aspects of dysexecutive syndrome in patients with moyamoya disease and its clinical subtypes.
Fang L; Huang J; Zhang Q; Chan RC; Wang R; Wan W
J Neurosurg; 2016 Aug; 125(2):299-307. PubMed ID: 26722860
[TBL] [Abstract][Full Text] [Related]
40. Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.
Vastrad B; Vastrad C; Tengli A; Iliger S
Arch Gynecol Obstet; 2018 Jan; 297(1):161-183. PubMed ID: 29063236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
